BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 15534049)

  • 1. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
    Ben-Haim S; Kupzov E; Tamir A; Israel O
    J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.
    Tatsumi M; Cohade C; Nakamoto Y; Wahl RL
    Radiology; 2003 Dec; 229(3):831-7. PubMed ID: 14593193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.
    Ben-Haim S; Kupzov E; Tamir A; Frenkel A; Israel O
    J Nucl Cardiol; 2006 Nov; 13(6):791-800. PubMed ID: 17174810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
    Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
    J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vascular 18F-FDG uptake with vascular calcification.
    Dunphy MP; Freiman A; Larson SM; Strauss HW
    J Nucl Med; 2005 Aug; 46(8):1278-84. PubMed ID: 16085583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans.
    Meirelles GS; Gonen M; Strauss HW
    J Thorac Imaging; 2011 Feb; 26(1):54-62. PubMed ID: 20562727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque.
    Menezes LJ; Kayani I; Ben-Haim S; Hutton B; Ell PJ; Groves AM
    Atherosclerosis; 2010 Jul; 211(1):136-40. PubMed ID: 20202634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
    Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
    J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of focal myocardial (18)F-FDG uptake and correlation with coronary calcifications by PET/CT].
    Garcia JR; Soler M; Fuertes S; Riera E; Moreno A; Lomeña F; Carrio I
    Rev Esp Med Nucl; 2011; 30(1):8-13. PubMed ID: 21208695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
    Rosen RS; Fayad L; Wahl RL
    J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction.
    Lee SJ; On YK; Lee EJ; Choi JY; Kim BT; Lee KH
    J Nucl Med; 2008 Aug; 49(8):1277-82. PubMed ID: 18632820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment.
    Jerushalmi J; Frenkel A; Bar-Shalom R; Khoury J; Israel O
    J Nucl Med; 2009 Jun; 50(6):849-53. PubMed ID: 19443604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG uptake and calcifications on positron emission tomography/computed tomography in octogenarians with severe aortic stenosis.
    Conrotto F; Lesca A; D'Ascenzo F; De Berardinis A; Grasso C; Sbarra P; Fava A; Baccega M; Marra S
    Minerva Cardioangiol; 2015 Jun; 63(3):187-92. PubMed ID: 25000124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG.
    Israel O; Mor M; Gaitini D; Keidar Z; Guralnik L; Engel A; Frenkel A; Bar-Shalom R; Kuten A
    J Nucl Med; 2002 Sep; 43(9):1129-36. PubMed ID: 12215549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
    Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN
    J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.